CDH1 promoter polymorphism and stomach cancer susceptibility

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1283-1286

  Li, Yi Ling ^a   Tian, Zhong ^a   Zhang, Jian Bing ^b   Fu, Bao Yu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

CDH1; Polymorphism; Stomach cancer; Susceptibility

Indexed keywords

UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CDH1 GENE; CONTROLLED STUDY; DOMINANT GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; PROMOTER REGION; PROTECTION; RECESSIVE GENE; RISK ASSESSMENT; STOMACH CANCER; TUMOR GENE; CHINA; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; STOMACH TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CHINA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84860318021     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0860-9     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
2. Pecina-Slaus N (2003) Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 3:17-23
3. Takeichi M (1991) Cadherin cell adhesion receptors as a mor-phogenetic regulator. Science 22:1451-1455 (Pubitemid 121000430)
4. Berx G, Becker K, Hofler H, Roy F (1998) Mutations in the human E-cadherin (CDH1) gene. Hum Mutat 12:226-237 (Pubitemid 28418891)
5. Nakamura A, Shimazaki T, Kaneko K (2002) Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502:19-24 (Pubitemid 34454994)
6. Li LC, Chui RM, Sasaki M (2000) A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60:873-879
7. Qiu LX, Li RT, Zhang JB, Zhong WZ, Bai JL, Liu BR (2009) The E-cadherin (CDH1)-160 C/A polymorphism and prostate cancer risk: a meta-analysis. Eur J Hum Genet 17:244-249
8. Zhang XF, Wang YM, Ge H (2008) Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 21:21-29
9. Shin Y, Kim IJ, Kang HC, Park JH, Park HR, Park HW (2004) The E-cadherin -347G?GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25:895-899 (Pubitemid 38886075)
10. Wu MS, Huang SP, Chang YT (2002) Association of the -160 C/A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94:1443-1448
11. Kuraoka K, Oue N, Yokozaki H (2003) Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 23:421-427
12. Park WS, Cho YG, Park JY (2003) A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 18:501-504 (Pubitemid 38030516)
13. Song CG, Huang CM, Liu X, Lu HS, Zhang XF, Huang W (2005) Association of -160(C[A) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:557-559 (Pubitemid 41499219)
14. Lu Y, Xu YC, Shen J (2005) E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 11:56-60 (Pubitemid 40090136)
15. Yamada H, Shinmura K, Ikeda S (2007) Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 42:1479-1485 (Pubitemid 350125545)
16. Humar B, Graziano F, Cascinu S (2002) Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 21:8192-8195 (Pubitemid 35454423)
17. Pharoah PD, Oliveira C, Machado JC (2002) CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 101:196-197 (Pubitemid 34970913)
18. Jenab M, McKay JD, Ferrari P (2008) CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer 44:774-780
19. Cattaneo F, Venesio T, Molatore S, Russo A, Fiocca R, Frattini M (2006) Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res 26:4627-4632 (Pubitemid 46031541)
20. Corso G, Berardi A, Marrelli D, Pedrazzani C, Garosi L, Pinto E (2009) CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev 18:46-49
21. Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL (2007) Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population. Ann Surg Oncol 14:2246-2249 (Pubitemid 47174898)
22. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
24. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
25. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315: 629-634 (Pubitemid 27387172)
26. Li C, Jiang Z, Liu X (2010) XPD Lys 751 Gln and Asp 312 Asn polymorphisms and bladder cancer risk: a meta-analysis. Mol Biol Rep 37:301-309
27. Zhu Y, Wang J, He Q, Zhang JQ (2010) Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis. Mol Biol Rep. doi:10.1007/s11033-010-0269-x
28. Qiu LX, Zhang J, Li WH, Zhang QL, Yu H, Wang BY (2010) Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility. Mol Biol Rep. doi:10.1007/s11033-010-0361-2
29. Liao RY, Mao C, Qiu LX, Ding H, Chen Q, Pan HF (2010) TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13, 662 cases and 14, 147 controls. Mol Biol Rep 37:3227-3232
30. Qiu LX, Wang K, Yang S, Mao C, Zhao L, Yao L (2010) Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Mol Biol Rep. doi:10.1007/s11033-010-0579-z
31. Tsukino H, Kuroda Y, Nakao H (2003) E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett 195:53-59
32. Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61 (Pubitemid 44698579)
33. Wacholder S, Chanock S, Garcia-Closas M (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442 (Pubitemid 38443646)